Intellectual Property, Ethics and the Market in the Era of Personalised Medicine

The second of a three-year conference series on Personalised Medicine, Ethics and the Market, this multidisciplinary two-day conference will focus on Intellectual Property (IP) issues. In particular, the programme will bring together academics, practitioners and industry experts to debate ways to promote biomedical innovation in the public interest. Although current debate tends to be polarized, a spectrum of opportunities exists between strong proprietary approaches and unrestricted openness, and the conference will discuss ways to address the challenges and opportunities for personalised medicine. Topics to be discussed include innovation in diagnostics, data sharing and access to clinical trial data, open innovation and the impact of patents on clinical practice. A programme for the event can be found here: